Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    A prospective trial of mechanical physiotherapy for lumbar disk prolapse

    Fifty consecutive patients with neuroradiologically confirmed lumbar disk prolapse, who responded to the first five daily physiotherapy sessions with pain centralization, were prospectively treated with mecha...

    D. Brötz, W. Küker, E. Maschke, W. Wick, J. Dichgans, M. Weller in Journal of Neurology (2003)

  2. No Access

    Article

    Expression and functional activity of osteoprotegerin in human malignant gliomas

    Apo2L/TRAIL-based therapy is a promising experimental approach to the treatment of human malignant gliomas. Osteoprotegerin (OPG) is a soluble decoy receptor for Apo2L/TRAIL that antagonizes Apo2L/TRAIL-induce...

    U. Naumann, W. Wick, R. Beschorner, R. Meyermann, M. Weller in Acta Neuropathologica (2004)

  3. No Access

    Article

    Reply to Lorenz et al.: Osteoprotegerin in the central nervous system

    U. Naumann, W. Wick, R. Beschorner, R. Meyermann, M. Weller in Acta Neuropathologica (2004)

  4. Article

    BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells

    Conditionally BCL-xL-overexpressing LNT-229 Tet-On glioma cell clones were generated to investigate whether the ‘antiapoptosis phenotype’ and the ‘motility phenotype’ mediated by BCL-2 family proteins in glioma c...

    M Weiler, O Bähr, U Hohlweg, U Naumann, J Rieger, H Huang in Cell Death & Differentiation (2006)

  5. No Access

    Article

    Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

    Methylating drugs such as temozolomide (TMZ) are widely used in the treatment of brain tumours (malignant gliomas). The mechanism of TMZ-induced glioma cell death is unknown. Here, we show that malignant gliom...

    W P Roos, L F Z Batista, S C Naumann, W Wick, M Weller, C F M Menck, B Kaina in Oncogene (2007)

  6. No Access

    Article

    Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice

    The expression of inhibitor of apoptosis (IAP) family members contributes to the resistance of human cancers to apoptosis induced by radiotherapy and chemotherapy. We report that the infection of malignant gli...

    U Naumann, O Bähr, H Wolburg, S Altenberend, W Wick, P Liston, A Ashkenazi in Gene Therapy (2007)

  7. No Access

    Article

    Tryptophan degradation in autoimmune diseases

    Recent evidence points to tryptophan (Trp) degradation as a potent immunosuppressive mechanism involved in the maintenance of immunological tolerance. Both Trp depletion and downstream Trp catabolites (TCs) ap...

    C. A. Opitz, W. Wick, L. Steinman, M. Platten in Cellular and Molecular Life Sciences (2007)

  8. Article

    Erratum: Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice

    Correction to: Gene Therapy (2007) 14, 147–161. doi:10.1038/sj.gt.3302845 Since the above publication, the authors have noticed that there are some errors in the western blots of Figures 1, 4, 6 and 7, which w...

    U Naumann, O Bähr, H Wolburg, S Altenberend, W Wick, P Liston, A Ashkenazi in Gene Therapy (2007)

  9. No Access

    Article

    Primäre ZNS-Lymphome

    Primäre ZNS-Lymphome (PZNSL) gehören zu den seltenen Gehirntumoren. Sie machen etwa 3% aller primären intrakraniellen Neubildungen aus; das mediane Erkrankungsalter liegt zwischen 60 und 65 Jahren. PZNSL führe...

    Prof. Dr. U. Schlegel, A. Korfel, E. Thiel, W. Wick, R. Kortmann in Der Onkologe (2009)

  10. No Access

    Article

    Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells

    The dioxin/aryl hydrocarbon receptor (AhR) is a transcription factor, which has been attributed a role in human cancerogenesis, cell cycle progression and transforming growth factor-β (TGF-β) signaling. As TGF...

    D Gramatzki, G Pantazis, J Schittenhelm, G Tabatabai, C Köhle, W Wick in Oncogene (2009)

  11. No Access

    Article

    Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome

    A. Wick, N. Schäfer, N. Dörner, D. Schemmer, M. Platten in Journal of Neuro-Oncology (2010)

  12. No Access

    Article

    Comment to: Parametric Response Map as an Imaging Biomarker to Distinguish Progression from Pseudoprogression in High-Grade Glioma: Pitfalls in Perfusion MRI in Brain Tumors

    Pseudoprogression is a recently recognized phenomenon which occurs mainly within the first 3 months after resection and radiochemotherapy of glioblastomas in up to 30% of cases. It refers to contrast enhanceme...

    A. Radbruch, M. Bendszus, W. Wick, S. Heiland in Clinical Neuroradiology (2010)

  13. No Access

    Article

    Neuroradiological Response Criteria for High-grade Gliomas

    The recently introduced new response criteria of the response assessment in neuro-oncology (RANO) working group and its clinical implications are the topic of this article. Establishing this working group as a...

    K. Lutz, A. Radbruch, B. Wiestler, P. Bäumer, W. Wick in Clinical Neuroradiology (2011)

  14. No Access

    Article

    Behandlung von Hirntumorpatienten

    Obschon die Behandlung maligner Gliome mit modernen operativen und strahlentherapeutischen Verfahren, dem Einsatz alkylierender und antiangiogener Systemtherapie sowie ersten molekular basierten Therapieentsch...

    Prof. Dr. M. Platten, W. Wick in Der Nervenarzt (2012)

  15. No Access

    Article

    Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment

    An essential mode of acquired resistance to radiotherapy (RT) appears to be promotion of tumor cell motility and invasiveness in various cancer types, including glioblastoma, a process resembling ‘evasive resi...

    M Weiler, P-N Pfenning, A-L Thiepold, J Blaes, L Jestaedt, J Gronych in Oncogene (2013)

  16. No Access

    Article

    A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network

    Ischemic strokes, intracranial hemorrhages (ICH) and deep venous thromboembolism (DVT) are clinically important events in patients with gliomas. In this multicentre, noninterventional observational study, curr...

    C. Seidel, B. Hentschel, M. Simon, O. Schnell, O. Heese in Journal of Neurology (2013)

  17. No Access

    Article

    Personalisierte Neuroonkologie

    Der Therapie hirneigener Tumoren steht ein fundamentaler Umbruch bevor. Dieser Umbruch wird aktuell weniger durch den Einsatz neuer zielgerichteter Therapien als durch die Definition molekularer Marker getrage...

    Prof. Dr. M. Platten, J.P. Steinbach, W. Wick in Der Nervenarzt (2013)

  18. No Access

    Article

    Biologische Grundlagen der Gehirnmetastasierung

    Bestehende Gehirnmetastasen, aber auch die Sorge davor, künftig an ihnen zu erkranken, werden zunehmend zu einer Einschränkung der Lebensqualität bzw. -erwartung von Patienten mit soliden Tumoren.

    Prof. Dr. F. Winkler, W. Wick in Der Onkologe (2014)

  19. Article

    Zerebrale Metastasen

    Prof. Dr. P. Vajkozcy, W. Wick, M. Bamberg in Der Onkologe (2014)

  20. No Access

    Article

    NDRG1 prognosticates the natural course of disease in WHO grade II glioma

    There is a lack of relevant prognostic and predictive factors in neurooncology besides mutation of isocitrate dehydrogenase 1, codeletion of 1p/19q and promoter hypermethylation of O ...

    J. Blaes, M. Weiler, F. Sahm, B. Hentschel, M. Osswald in Journal of Neuro-Oncology (2014)

previous disabled Page of 2